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Abstract
Purpose Little is known about estimating utilities for
comorbid (or ‘joint’) health states. Several joint health state
prediction models have been suggested (for example,
additive, multiplicative, best-of-pair, worst-of-pair, etc.),
but no general consensus has been reached. The purpose of
the study is to explore the relationship between health-
related quality of life (HRQoL) and increasing numbers of
diagnoses.
Methods We analyzed a large dataset containing
respondents’ ICD-9 diagnoses and preference-based
HRQoL (EQ-5D and SF-6D). Data were stratified by the
number of diagnoses, and mean HRQoL values were esti-
mated. Several adjustments, accounting for the respon-
dents’ age, sex, and the severity of the diagnoses, were
carried out. Our analysis fitted additive and multiplicative
models to the data and assessed model fit using multiple
standard model selection methods.
Results A total of 39,817 respondents were included in
the analyses. Average HRQoL values were represented
well by both linear and multiplicative models. Although
results across all analyses were similar, adjusting for
severity of diagnoses, age, and sex strengthened the linear
model’s performance measures relative to the multiplica-
tive model. Adjusted R2 values were above 0.99 for all
analyses (i.e., all adjusted analyses, for both HRQoL
instruments), indicating a robust result.
Conclusions Additive and multiplicative models perform
equally well within our analyses. A practical implication of
our findings, based on the presumption that a linear model
is simpler than an additive model, is that an additive model
should be preferred unless there is compelling evidence to
the contrary.
Keywords EQ-5D  SF-6D  Comorbidity  Health-state
utility value  Health-related quality of life
Introduction
Economic evaluation of healthcare interventions is typi-
cally carried out using quality-adjusted life years (QALYs)
as the outcome measure. The QALY combines length of
life and health-related quality of life (HRQoL) in a single
metric. As an addition to direct empirical comparison of
QALY gain of available treatment options, modeling of
cost utility is becoming increasingly common, since mod-
eling based on existing data is more flexible and affordable
than tailoring clinical tests to every scenario of potential
interest. Such modeling rests on extensive use of preex-
isting recorded values representing the mean HRQoL loss
associated with particular health conditions—so-called
health-state utility values (HSUVs). This has created a
demand for values for common ailments, which in turn has
spurred on an effort to estimate catalogs of HSUVs asso-
ciated with specific diagnoses [1, 2]. Priority setting in
health care is becoming an increasingly important field for
policy makers as the medical frontier is advancing ahead of
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budget constraints [3]. Access to sound estimates of health
state utilities is important in order to ensure that resources
are allocated in an efficient manner when evaluating
treatments and interventions.
Modeling is complicated by the fact that patients fre-
quently have more than one health problem, that is, are
comorbid. Comorbidity is an ubiquitous and high-impact
phenomenon [4], to the extent that three in four Americans
above 65 years of age are diagnosed with two or more
chronic diseases. In order to accurately estimate the QALY
gain of alternative interventions in target populations, ana-
lysts need information about the HSUVs of health states
characterized by being a combination of medical conditions.
Several efforts to construct catalogs of off-the-shelf
HSUVs representing the mean HRQoL of various sub-
populations have been undertaken [1, 2, 5]. These studies
have in common that they are based on multivariate linear
regression modeling on large datasets and thus can be said
to incorporate quite accurate information while taking into
account a number of factors which influence HRQoL. This
is a suitable way for cost-utility modeling within a specific
population where information (socio-demographics, diag-
noses, etc.) is abundant. However, this method is not aimed
at gaining knowledge about how comorbidities per se may
interact with HRQoL. In particular, this paradigm assumes
additive effects of having several diagnoses and therefore
may be inadequate to inform on the relationship between
comorbidity and HRQoL. A study by Sullivan et al. [6]
looks at the impact of the number of chronic conditions on
HRQoL, in a similar setting, concluding that the number of
chronic conditions of an individual is a very important
predictor of HRQoL.
A rather different approach to dealing with comorbidity
is represented by attempts at identifying good mathematical
models of comorbidity [4]. A mathematical model of
comorbidity assumes that the HSUV of a compound health
state can be estimated from the HSUVs of the component
health states. Different models have been studied and
compared, without any clear best fit [7, 8]. Research has
mainly focused on combining single-state health state val-
ues into joint-state health state values [9–13], because large
enough populations with any given combination of three
distinct diagnoses are too small. Several joint health state
predictors have been suggested (i.e., additive, multiplica-
tive, best-of-pair, worst-of-pair, etc.), but no general con-
sensus has been reached [7]. The various models (additive,
multiplicative, minimum, etc.) lead to diverging predic-
tions. An additive model implies that preferences should
decline linearly with increased diagnoses; the multiplicative
model implies diminishing marginal loss of HRQoL as a
function of additional diagnoses. The best and worst-of pair
models both imply a rapidly flattening HRQoL as diagnoses
add up.
Investigating the mathematical relationship between
single-state HSUVs and their corresponding joint-state
HSUV is likely to be insufficient to uncover a general
trend. Without any preconceptions about the preferred
functional form, the purpose of this study is to explore the




We obtained data from the 2001 and 2003 Medical Expen-
diture Panel Survey (MEPS) [14]. These MEPS datasets
contain detailed information on non-institutionalized US
respondents’ health and socio-demographics, as well as self-
reported HRQoL measured by two multi-attribute utility
instruments, the EQ-5D and SF-6D (further details are
provided below; the choice of years was based on the
availability of contemporaneous EQ-5D and SF-6D data).
The MEPS Web site also provides, in an auxiliary medical
conditions file, a list of International Classification of Dis-
eases, Ninth Revision, Clinical Modification (ICD9-CM)
diagnose codes, which are linked to individuals by an
identification variable. For privacy reasons, ICD9-CM
diagnoses are provided as a truncated, 3-digit code in the
MEPS file. For example, this means that an individual
diagnosed with ‘hypertrophy of nasal turbinates’ (ICD9-CM
code 478.0) and ‘polyp of vocal cord or larynx’ (ICD9-CM
code 478.4) will be coded with two occurrences of the
3-digit ICD9-CM code 478.
HRQoL instruments
The EQ-5D is one of the most frequently used instruments to
assess HRQoL in health economic evaluation [15], requiring
individuals to describe their health state across five dimen-
sions: mobility, self-care, usual activities, pain and dis-
comfort, and anxiety and depression. The 2001 and 2003
MEPS included the three-level version of the EQ-5D, in
which each of the five dimensions has response options ‘no
problems,’ ‘some problems’ or ‘extreme problems’. EQ-5D
utility values were estimated using the preference-based
algorithm published by Shaw et al. [16]. SF-6D scores were
derived from the 12-Item Short-Form Health Survey (SF-12)
[17]. The SF-6D is a multi-attribute utility instrument
comprising items for the following six dimensions: physical
functioning, role limitations (physical and emotional), bod-
ily pain, vitality, social functioning, and mental health.
Seven of the 12 items from the SF-12 are used to derive an
SF-6D index score, and the six dimensions have between
three and five levels of severity. SF-6D utility values were
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calculated according to the preference-based algorithm
published by Brazier and Roberts [18].
Inclusion criteria
We denote by Pk the collection of MEPS individuals who
satisfy the following conditions: (1) at least 18 years of
age, (2) have valid data for both HRQoL instruments, and
(3) who have exactly k registered diagnoses in the MEPS
medical condition file. Similarly, for an ICD9-diagnosis, D,
the symbol PD denotes the set of individuals who are at
least 18 years of age, have valid HRQoL data, and are
registered with diagnosis D.
Statistical analysis
The primary aim of the study was to investigate how
HRQoL is affected by additional medical diagnoses. To
find support for generalizability beyond one specific
HRQoL instrument, we analyzed both the EQ-5D and the
SF-6D data from the MEPS dataset.
For each respondent in the MEPS 2001–2003 data, we
computed an auxiliary variable named ‘Number of (regis-
tered ICD9) Diagnoses’ (NoD); a variable which simply
counts the number of distinct ICD9 diagnoses assigned to
the individual via the MEPS medical conditions file (Note:
V-codes from the MEPS medical conditions files were
omitted; this is further discussed in the Discussion section).
Due to the 3-digit truncation of ICD9-codes, some
responders were registered with more than one occurrence
of the same ICD9-code. Such instances were counted with
multiplicity, since they originate from different ICD9-
codes in the underlying dataset. Next, the data were strat-
ified according to the NoD variable into Pk subgroups. To
ensure robust estimates of mean HRQoL for the NoD-de-
fined strata, a pre-defined threshold of 1000 individuals, per
strata, was required for inclusion in further analyses. For
each strata satisfying this threshold, mean EQ-5D and SF-
6D estimates were calculated. To assess the functional
relationship between HRQoL and NoD, we next fitted three
models to the aggregated data:
Model A : HRQoL ¼ aþ b  NoD
Model B : HRQoL ¼ aþ b  NoD þ b2  NoD2 and
Model C : HRQoL ¼ a  bNoD
Model A may support an additive—or linear—relationship.
Model B may support a linear, an approximate multi-
plicative or an accelerating HRQoL loss relationship
between NoD and HRQoL, depending on the signs, the
magnitudes and the associated p values of the coefficients b
and b2. Model C, which is equivalent to the model
ln HRQoLð Þ ¼ a0 þ b0  NoD, reflects a multiplicative
relationship between HRQoL and NoD. In all three models,
the intercept (a) is interpretable as the estimated mean
HRQoL of individuals with zero diagnoses. In Models A
and B, a fixed decrement b is subtracted for each additional
diagnosis; in Model B, an extra fixed adjustment of b2 
NoD is added to the estimate. For Model C, instead of a
fixed decrement from a, the estimate is multiplied with a
factor of b for each additional diagnosis; whence a good fit
of this model may be taken as support of an underlying
multiplicative relationship.
Because early inspection of plots of the values suggested
the models would provide very similar fits, several model
selection statistics were computed to explore our research
question: regression coefficients, p values for the regres-
sion coefficients, the adjusted R2’s, the root-mean-squared
error (RMSE), and the leave-1-out root-mean-squared
residuals (L1O-RMSR) [19, 20], which is the analogous
index of the model’s predictive value [21]. The residuals
that enter the L1O-RMSR index are the distance between
the predicted value and the observed value for HRQoL for
Pk, when leaving out the estimate of Pk when estimating
the model (i.e., a standard leave-1-out cross-validation
approach). As Model A is a nested specification of Model
B, the two can be compared directly using standard anal-
ysis of variance methods, i.e., a nonsignificant regression
coefficient for the quadratic term indicates over-specifica-
tion. Because Models A and C are not nested models, there
is no canonical best way of comparing them. As a further
aid in interpreting the results, we also calculated the root-
mean-squared distance (RMSD) between the fitted values
of Model A and Model C. The RMSD is simply the
Euclidean distance between the two models’ fitted values
or equivalently the standard RMSE of Model A’s fitted
values regarding Model C’s fitted values as the observed
values. This last statistic is non-standard and therefore
should be interpreted with caution. On the other hand,
mathematically, the RMSD as defined here is simply the
Euclidean distance between the fitted values of the two
models, measured by the same metric as is used for the
RMSE statistic. Therefore, it has one obvious interpreta-
tion: the relative differences in magnitude of the RMSDs
between the two models, and the two models’ RMSEs, say
something about the mutual distance between the fitted
values relative to the fitted values to the observed ones. As
for the regressions, all means for the RMSE’s and the
RMSD’s were weighted by the strata’s relative sizes.
Adjusting for age, sex, and severity
Correlations between demographic factors, such as age or
gender, and HRQoL, or between the number of diagnoses
and diagnosis severity, may introduce bias unless accoun-
ted for in the analysis. An ideal dataset would ensure that
Qual Life Res (2015) 24:2823–2832 2825
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Pk?1 is comprised of individuals from Pk after being
affected by one more diagnosis. Within our dataset, this
assumption does not hold because of inevitable differences
in age, sex, severity, and numerous other factors. Accord-
ingly, we performed a number of adjustments (age, sex,
and severity) to compensate for these potential sources of
bias. A detailed explanation of the adjustment methods is
reported in Appendix. Briefly, for the severity adjustment,
a new variable called ‘severity-weighted number of diag-
noses’ (SWNoD) was computed for each respondent by
summing severity weights rather than the (unadjusted)
number of diagnoses. Note that the severity weights were
calculated separately for EQ-5D and SF-6D, so that, for
example, when investigating the relationship between
SWNoD and EQ-5D, the severity weights used were
computed with respect to the EQ-5D. Furthermore, for
each of the HRQoL instruments, we computed severity
weights using two sets of criteria. ‘Relaxed’ weights were
calculated for all diagnoses for which we had at least one
observation of an individual with no other diagnoses. The
‘strict’ weights required at least 10 sole-diagnosis indi-
viduals for a weight to be estimated.
In total, four analyses were carried out for each of the
two HRQoL instruments (see Table 1 for an overview). All
analyses were carried out in the statistical software R [22];
the models were fitted with the built-in linear regression
modeling lm-function.
Results
The pooled 2001–2003 material contains a total of 67,771
individuals. A total of 47,178 individuals were 18 years or
older, out of which 39,817 (84.4 %) had valid data for both
MAUIs (which were administered to 18? year olds only).
The age variable ranged over 18–85 (mean 45.36); 45.5 %
were males. The NoD variable ranged over 0–45 (mean
3.28). A total of nine strata P0,…,P8 (consisting of patients
characterized by having exactly 0,…,8 diagnoses)
remained after omitting strata with fewer than a thousand
respondents. Table 2 gives descriptive statistics for the
strata P0–P8: unadjusted means for the strata’s mean
HRQoL as measured by EQ-5D and SF-6D, mean age,
percentage of males, strata size, and relative share (of the
39,817 with valid HRQoL information).
The age distribution was skewed toward more elderly
individuals in the strata representing more diagnoses, with
a near-linear relationship between the strata’s mean over
age and NoD. It is also the case that in general, the
respondents with more diagnoses also have more severe
diagnoses, as is evident by the perfect correlation
(r = 1.000) between NoD and mean SWNoD (Table 2);
indeed, the individuals with eight diagnoses have on
average almost nine severity-adjusted diagnoses.
Unadjusted analyses
For both HRQoL indices, the parsimonious linear models
exhibited R2[ 0.995, indicating that a linear relationship
between NoD and HRQoL explains the average values very
well. Summaries of the regression models are presented in
Table 3, together with results from the age-, sex-, and
severity-adjusted variables.
Adjusted analyses
The regression model of EQ-5D as a function of age and
sex within P0-stratum was significant for both independent
variables (p\ 0.000) and predicted age–sex reference
values.
uEQ a; sð Þ ¼ 0:9697  0:0007  aþ 0:0085  s
For SF-6D, only the sex variable was significant s
(p\ 0.000), and after leaving out the age variable
(p[ 0.05), the model predicted age–sex reference values
as
uSF a; sð Þ ¼ 0:8487 þ 0:0237  s
Of the 555 distinct ICD-9 diagnoses in the MEPS
medical conditions file, there were 373 diagnoses for which
a severity weight was obtainable from at least one indi-
vidual (‘relaxed’ definition) and 124 diagnoses that at least
Table 1 List of analyses
carried out to compare linear
and multiplicative models
Analysis number HRQoL instrument Adjustment(s)
1 EQ-5D None
2 EQ-5D Age and sex
3 EQ-5D Age, sex, and severity (‘relaxed’ definition)
4 EQ-5D Age, sex, and severity (‘strict’ definition)
5 SF-6D None
6 SF-6D Age and sex
7 SF-6D Age, sex, and severity (‘relaxed’ definition)
8 SF-6D Age, sex, and severity (‘strict’ definition)
2826 Qual Life Res (2015) 24:2823–2832
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10 individuals had as their sole diagnosis (‘strict’ defini-
tion). After omission of individuals with non-weighable
diagnoses, for the two different severity-adjustment crite-
ria, the procedure retained 36,599 (91.92 %) for the relaxed
inclusion and 25,858 (64.94 %) for the strict inclusion. The
adjustments were non-trivial: The fraction of respondents
who obtained a (rounded) SWNoD which differed from
their originally computed NoD category ranged from
9.23 % (Analysis 8: ‘strict’ SF-6D-based SWNoD) to
44.97 % (Analysis 3: ‘relaxed’ EQ-5D SWNoD).
The computed model selection statistics (see Table 3)
illustrate a good fit for all models, with very high adjusted
R2 values throughout. The RMSE column shows that all
three models give good fitted versus observed values.
Furthermore, the quadratic Model B, with its additional
parameter, tends to outperform the two other models with
respect to this metric. The L1O-RMSR gives a different
picture: Here the Model B under-performs, suggesting
over-specification. The Model C performs slightly better
than the Model A according to the L1O-RMSR metric;
however, this gap is closed after adjusting for age, sex, and
severity. In the L1O-RMSR metric, all models improve
their fit as adjustments are made, except for analyses 4 and
8 which correspond to the strict inclusion. The RMSD
column reports the distance between the predictions of the
Models A and C. This column shows that the difference
between the two models’ predictions is smaller than the
difference between the two models’ respective predictions
and the observed values.
For better visualization of the results presented in
Table 3, Fig. 1a, b provides a graphical image of two of the
models (Models 4A–C and 8A–C). We see that in both
cases, the three Models A–C provide similar fits and that
the immediate impression is that the parsimonious linear
model describes the trend well.
Discussion
The most striking property of the result reported in
Table 3 is the similarity between the three models.
Models A, B, and C display very similar fit indices, and
the RMSE values suggest that all three models estimate
the data well. Before adjustments for age, sex, and
severity, Models B and C slightly improve the fit com-
pared to the linear Model A. As expected, with its one
extra degree of freedom, the quadratic Model B tends to
beat the two other with a few thousands of a unit; how-
ever, looking to the L1O-RMSR column, it appears over-
specified. After adjustments are made, Model A outper-
forms or matches Model C.
Examining the RMSE and L1O-RMSR for Models A
and C does not identify either as being superior. If we
assume that the adjusted analyses are the most appropriate,
the improved fit of Model A suggests a possible underlying
true additive relationship. The results also suggest that
Models A and C are more similar to each other than to the
underlying data, as reflected by the RMSD values being
smaller than the two models’ RMSE statistics.
On average, little is gained from adding a quadratic term
to a linear model for predicting HRQoL loss associated
with extra diagnoses. This suggests that the general trend,
on average, is adequately captured by a linear model. That
this in conflict with many studies from the joint-state lit-
erature may be due to the fact that an additive model,
working directly with the HRQoL losses associated with a
Table 2 Descriptive statistics for each stratum defined by the number of diagnoses
NoD n (%) Cumulative n (%) Age Male (%) EQ-5D SF-6D NSWNoDa
0 7089 (17.8) 7089 (17.8) 36.9 (13.5) 56.9 0.948 (0.1) 0.862 (0.1) 0.000
1 7384 (18.6) 14,473 (36.4) 39.4 (14.6) 52.9 0.921 (0.1) 0.835 (0.1) 1.000
2 6194 (15.6) 20,667 (51.9) 42.4 (16.0) 50.2 0.893 (0.1) 0.811 (0.1) 2.029
3 4936 (12.4) 25,603 (64.3) 45.3 (16.9) 43.7 0.867 (0.2) 0.791 (0.1) 3.095
4 3624 (9.1) 29,227 (73.4) 48.9 (17.0) 39.6 0.838 (0.2) 0.769 (0.1) 4.182
5 2813 (7.1) 32,040 (80.5) 51.6 (17.4) 36.7 0.817 (0.2) 0.748 (0.1) 5.292
6 2093 (5.3) 34,133 (85.7) 53.4 (17.6) 35.0 0.785 (0.2) 0.723 (0.2) 6.435
7 1540 (3.9) 35,673 (89.6) 55.6 (17.3) 33.4 0.773 (0.2) 0.712 (0.1) 7.543
8 1212 (3.0) 36,885 (92.7) 58.2 (16.8) 31.5 0.742 (0.2) 0.686 (0.2) 8.713
Pearson’s correlation coefficients (r) 0.997 -0.979 -0.998 -0.998 1.000
Values are means (standard deviations) unless stated otherwise. The r-row reports Pearson’s correlation coefficients (r) between the number of
diagnoses (NoD) and the mean values in the corresponding column. As a consequence of the a priori decision to exclude stratum with fewer than
1000 individuals, data for 7.4 % of the dataset were omitted from further analysis
NoD number of diagnoses, NSWNoD normalized severity-weighted number of diagnoses
a The derivation of the normalized severity weights is described in ‘Appendix’
Qual Life Res (2015) 24:2823–2832 2827
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single-state condition, does not account properly for the
HRQoL loss present also among those with no diagnoses.
Strengths and limitations
While several studies investigating the impact of having
two simultaneously existing diagnoses (the joint-state lit-
erature) have been carried out [9–13], the more general and
underlying question of how diagnoses impact HRQoL has
not been previously addressed. The study undertaken by
Sullivan et al. does to some extent overlap with this study
because they both incorporate respondents with multiple
diagnoses. However, whereas Sullivan’s model is designed
to predict individual HRQoL, given rich information about
the individuals’ age, sex, diagnoses, and other covariates,
our model is solely focusing on the independent impact of
diagnoses on HRQoL. Put simply, Sullivan focuses on the
HRQoL of individuals, with a rich model, while we use a
sparse model to focus on the functional relationship
between the number of diagnoses and HRQoL.
Previous studies [9, 11–13] have used the clinical clas-
sification categories (CCCs) as a crude measure of disease.
The CCCs also include V-codes; ‘supplementary Classifi-
cation of Factors Influencing Health Status and Contact
with Health Services (V01.0–V91.99) is provided to deal
with occasions when circumstances other than a disease or
injury (Codes 001–999) are recorded as a diagnosis or
problem’ [23]. As such, V-codes carry with it information
about other factors than morbidity qua morbidity. Using the
truncated CCC information—or defining NoD-stratum—
without omitting the V-codes thus may lead to groups with
possibly biased HSUV values. The working directly with
the ICD-9 diagnoses in this study permits omitting V-codes
and is a strength of our analyses.
The interpretation of our results depends on patients with
n ? 1 diagnoses being comparable to patients with
Table 3 Key statistics for the
regression models across the
eight analyses described in
Table 1
Analysis and modela a b b2 P2 Adj R
2 RMSDb RMSE L1O-RMSR
1 A 0.9464 -0.0261 – – 0.9972 0.0029 0.0051
1 B 0.9486 -0.0287 0.0004 0.0592 0.9983 0.0020 0.0021 0.0042
1 C 0.9488 0.9700 – – 0.9983 0.0021 0.0037
2 A 0.9464 -0.0238 – – 0.9972 0.0026 0.0046
2 B 0.9484 -0.0260 0.0003 0.0874 0.9981 0.0017 0.0020 0.0041
2 C 0.9484 0.9729 – – 0.9981 0.0020 0.0037
3 A 0.9505 -0.0271 – – 0.9974 0.0027 0.0049
3 B 0.9516 -0.0286 0.0002 0.3210 0.9975 0.0020 0.0025 0.0053
3 C 0.9527 0.9690 – – 0.9974 0.0027 0.0043
4 A 0.9515 -0.0237 – – 0.9962 0.0026 0.0060
4 B 0.9510 -0.0230 -0.0001 0.6261 0.9958 0.0014 0.0025 0.0089
4 C 0.9528 0.9734 – – 0.9942 0.0032 0.0063
5 A 0.8582 -0.0220 – – 0.9957 0.0030 0.0049
5 B 0.8609 -0.0251 0.0005 0.0198 0.9981 0.0016 0.0019 0.0041
5 C 0.8600 0.9723 – – 0.9980 0.0020 0.0033
6 A 0.8583 -0.0212 – – 0.9957 0.0029 0.0046
6 B 0.8608 -0.0239 0.0004 0.0391 0.9977 0.0015 0.0020 0.0043
6 C 0.8600 0.9735 – – 0.9977 0.0021 0.0033
7 A 0.8613 -0.0224 – – 0.9993 0.0012 0.0019
7 B 0.8621 -0.0234 0.0001 0.1134 0.9995 0.0016 0.0010 0.0017
7 C 0.8631 0.9719 – – 0.9991 0.0013 0.0020
8 A 0.8612 -0.0201 – – 0.9955 0.0023 0.0059
8 B 0.8621 -0.0215 0.0002 0.2913 0.9957 0.0011 0.0021 0.0058
8 C 0.8622 0.9752 – – 0.9958 0.0021 0.0049
Adj. R2 adjusted R2, RMSD root-mean-squared difference, RMSE root-mean-squared error, L1O-RMSR
leave-one-out root-mean-squared residual
a Model A is the linear/additive model, Model B the quadratic, and Model C the log-transformed/multi-
plicative model (for further details, see Methods section). Due to the model specifications, b2 coefficients
are only relevant for Model B; p1 is the associated p value for the b1 coefficient. b1 coefficients for the three
models, across all eight analyses, were significant at the 0.0001 level
b This statistic is the distance between the fitted values from Models A and C, analogous to the RMSE
which is the distance between the fitted values and the observed values. The concept of distance is the
standard (weighted) Euclidean distance between the sets of observed and/or fitted values
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n diagnoses with the exception of the additional health
problem. The major concern is that patients with more
diagnoses may be afflicted with problems of different
severity from the ones with patients with fewer diagnoses.
However, the extent to which this is a problem for our
analyses directly transfers to all attempts at determining the
functional form for addition of health problems. Adjusting
for severity goes some way toward ensuring such compa-
rability. Still, the validity of our findings regarding the
relationship between number of diagnoses and HSUVs
depends on the generalizability of the MEPS data with
regard to that relationship. Our analyses are made under the
assumption that sampling error and missingness are random
with respect to the functional relationship under scrutiny.
Since we did not gather the data ourselves, we have
limited control of the quality of the data. However, it is
unlikely that there should be any systematic biases in the
collection process that would affect HRQoL values as a
function of NoD. The data were collected in an outpatient
setting, meaning that we cannot necessarily generalize to,
e.g., a hospitalized population.
Even though our analyses are carried out on mean values
computed over populations with 1000? members, only nine
strata were included. This means that the linear relationship
observed may not describe the actual trend for patients with
nine or more diagnoses. We do not suggest that the
regression models are useful in themselves, only that they
help investigate the underlying relationship between mor-
bidity, as measured by diagnoses, and HRQoL.
The observed range of mean HRQoL values in our sample
(0.948–0.742 for EQ-5D and 0.862–0.686 for SF-6D) may
limit our ability to distinguish between the predictions from
the additive and the multiplicative approaches. The problem
could be ameliorated by looking specifically at severe
Linear model (Model A)
Quadratic model (Model B)




















Fig. 1 Illustration of model fit
for Models A, B, and C for the
fully adjusted analyses (age,
sex, and severity) for the EQ-5D
(a) and SF-6D (b). With
reference to Table 3,
a corresponds to analyses 4-A,
4-B, and 4-C; b corresponds to
analyses 8-A, 8-B, and 8-C
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diagnoses, but this would come at the cost of substantially
reducing the number of available observations. As it is, the
observed range of HRQoL values is based on more than
93 % of the population sample, suggesting that we are cov-
ering most of the relevant range of disease in the population.
Conclusions
The three model specifications explored in this analysis—
the linear (A), the linear with a quadratic term (B), and the
multiplicative (C) (see the ‘‘Methods’’ section)—were vir-
tually identical, indicating that a linear model adequately
represents the trend on average. Occam’s razor suggests that
the simplest model should be preferred. On this basis, we
recommend discontinuing the search for a general multi-
plicative model. The study does not support the general
notion of declining marginal disutility of health.
The observation that the average over thousands of
patients with hundreds of different diagnoses match a linear
function through number of diseases does not indicate that
there exists a general linear model that can predict the mean
HRQoL for a given combination of diagnoses from the
HRQoL of the constituent diagnoses; the averages in ques-
tion collapse a wide distribution of diagnoses that mask each
other, exacerbate each other, or behave erratically in com-
bination. The use of any general model, including the addi-
tive, is likely to lead to predictions that deviate substantially
from reality in most cases even if the deviation is unbiased
across studies. We recommend using empirical estimates of
the HRQoL for patient groups with combination health states
where this is possible. When such estimates are unattainable,
any non-empirical estimates should be made based on
expertise that allows predictions of the manner in which the
constituent health problems should be expected to interact.
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Appendix: Details of the age, sex, and severity
adjustments
Age and sex adjustment
Age- and sex-adjusted HRQoL values were computed, for
the EQ-5D and SF-6D, in the following way. In step 1, a
linear regression model was fitted to the P0 stratum (i.e.,
those individuals with zero diagnoses):
ui ¼ b1 þ b2  ai þ b3  si þ i
where ui is individual i’s HRQoL (either EQ-5D or SF-6D),
ai is age (in years), and si is a sex-dummy. In step 2, the
estimated age- and sex-specific reference value (for each
pair a and s)
ua;s ¼ b1 þ b2  aþ b3  s
yielded age- and sex-specific deviancy from the mean
HRQoL for the P0-stratum (u0) by:
u0  ua;s
This enabled us to define an age- and sex-adjusted
(ASA) HRQoL values (u0) for each individual:
u0i ¼ ui þ u0  uai;si
 
This approach does not attempt to minimize residuals on
HRQoL given age and sex for the whole MEPS panel. Rather, it
assumes that there is an independent effect of age and sex on
HRQoL, which does not interact with diagnoses. Once the
effect has been estimated, we adjust for it by taking away from
(or giving back to) all individuals the HRQoL gained (or lost) as
a result of their age and sex. The reason for restricting the
regression model that estimates the age- and sex-specific
HRQoL decrement toP0 is that this stratum is where the specific
age and sex impact on HRQoL is disentangled from that of the
diagnoses. It may help to understand the adjustment by con-
sidering that when individual i belongs to an age–sex class with
higher predicted HRQoL than the average zero-diagnosis
individual (u0\uai;si), then i’s HRQoL will be decreased by
u0  uai;si [ 0. Inverting the inequalities shows that individu-
als with lower-than-average reference value for their HRQoL
will have increased HRQoL as with this adjustment.
Severity adjustment
Severity weights were computed for the various diagnoses
contained within the MEPS dataset by performing sub-
group analyses on individuals with exactly D as their
diagnosis, i.e., respondents in the P1 stratum. However, age
and sex differences between diagnosis-defined subpopula-
tions could also interfere. If some diagnosis subgroups
were predominantly made up of young males and others of
older females, the presence of age and/or sex gradients for
HRQoL could bias the computed severity weights, so the
procedure described below was performed with respect to
age- and sex-adjusted HRQoL values.
In step 1, we excluded all individuals who had a diagnosis
that did not occur as the sole diagnosis of at least one
respondent in the MEPS panel. In step 2, based on respondents
with exactly one diagnosis, we estimated the mean HRQoL
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loss, dD (for both the EQ-5D and SF-6D), associated with each
diagnosis. In step 3, a severity weight was assigned to each
diagnosis:
sD ¼ dD=d
where d is the average over all the dD’s computed in step 2.
This operation results in a normalized severity weight such
that sD[ 1 means that the diagnosis has a greater-than-
average impact on HRQoL, and sD\ 1 has a less-than-
average impact.
Step 1 ensures that all remaining individuals may have a
severity weight assigned to all of their diagnoses. Note also
that steps 2 and 3 result in one distinct severity weights set
for each HRQoL instrument (in our case, EQ-5D and SF-
6D). Step 1 necessitates discarding individuals who have
diagnoses that are non-weighable (because no one has only
that diagnosis; hence its independent impact on HRQoL
cannot be estimated). The subsequent re-stratification (de-
scribed below in step 4) resulted in somewhat smaller strata.
Fourteen of the 18 strata retained more than one thousand
individuals; the exceptions were stratum P8 (n = 763) under
the relaxed inclusion, and strata P6 (n = 721), P7 (n = 431)
and P8 (n = 272) under the strict inclusion.
In step 4, a new variable ‘severity-weighted number of
diagnoses’ (SWNoD) was computed for each respondent
by summing severity weights rather than the (unadjusted)
number of diagnoses. For example, a respondent with three
diagnoses D1, D2, and D3 with severity weights 0.9, 0.95,
and 1.70 would obtain a raw SWNoD of 3.55, reflecting the
increased severity. SWNoD values are subsequently roun-
ded to the nearest integer to permit re-stratification of the
data.
Appendix Fig. 2 provides a schematic representation of
the age, sex, and severity adjustment methods.
For further motivation for why the severity adjustment is
important, particularly when dealing with our research
question, consider the following example:
Example: Assume that, unknown to the observers, diagnoses can
be grouped into two types M and S, where diagnoses of type M is
associated with a HRQoL loss of 0.197 (mild) and diagnoses of
type S one of 0.225 (severe). Thus, the measured HRQoL of an
individual is (on average) 0.803 for individuals with a mild
diagnosis, and 0.775 for individuals with a severe diagnosis.
Moreover, assume that severe diagnoses are rare among those
individuals with only one diagnosis, say in a 1:9 relationship to
the mild ones, while they are ubiquitous among those with two
diagnoses. In this world, we would measure the average HRQoL
to be 90:803 þ 0:777
10
¼ 0:800 among those with only one
diagnosis. How would we interpret a measured average of 0.600
in HRQoL among those with two diagnoses?
Fig. 2 Schematic of
adjustments for age, sex, and
severity of diagnoses. Arrows
show dependencies. Age and
sex adjustment is made on the
basis of the P0 stratum, prior to
adjusting for severity on the
basis of the P1 stratum.
Following the severity
adjustment of diagnoses, we
have a new stratification of the
dataset (indicated on the right-
hand side)
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Certainly, this estimate fits with an additive model, since the average
measured HRQoL loss associated with one diagnosis is 0.200 and
1 – 2 9 0.200 = 0.600. But we also note that 0.7752 = 0.600
which fits with a multiplicative model when we take into account
that in our example all those who suffer from two diagnoses suffer
from two severe ones
In the example above, a multiplicative relationship is
disguised as an additive one. By choosing different values
and case mixes of mild and severe diagnoses, one can of
course construct a model in which the opposite phe-
nomenon is present just as easily.
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